Dyslipidaemia and Hospitalisation

Summary:

Hospitalisation is found among people with Dyslipidaemia, especially for people who are male, 60+ old.

The study analyzes which people have Hospitalisation with Dyslipidaemia. It is created by eHealthMe based on reports of 28 people who have Dyslipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 842 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,715 drugs and 1,133 conditions by eHealthMe. Check the latest studies of Hospitalisation.



On Jul, 11, 2026

28 people who have Dyslipidaemia and Hospitalisation are studied.

Would you have Hospitalisation when you have Dyslipidaemia?

Gender of people who have Dyslipidaemia and experienced Hospitalisation *:

  • female: 39.13 %
  • male: 60.87 %

Age of people who have Dyslipidaemia and experienced Hospitalisation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.26 %
  • 30-39: 0.0 %
  • 40-49: 5.26 %
  • 50-59: 10.53 %
  • 60+: 78.95 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 25.00%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 21.43%
  3. Depression: 4 people, 14.29%
  4. Indigestion: 3 people, 10.71%
  5. Pain: 3 people, 10.71%
  6. Nausea (feeling of having an urge to vomit): 3 people, 10.71%
  7. Nausea And Vomiting: 3 people, 10.71%
  8. Type 2 Diabetes: 2 people, 7.14%
  9. Stress And Anxiety: 2 people, 7.14%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.14%

Common drugs taken by these people *:

  1. Repatha: 7 people, 25.00%
  2. Amlodipine: 5 people, 17.86%
  3. Adcirca: 5 people, 17.86%
  4. Aspirin: 5 people, 17.86%
  5. Dimenhydrinate: 3 people, 10.71%
  6. Simvastatin: 3 people, 10.71%
  7. Epoprostenol Sodium: 3 people, 10.71%
  8. Ondansetron: 3 people, 10.71%
  9. Prednisone: 3 people, 10.71%
  10. Opsumit: 3 people, 10.71%

Common symptoms for these people *:

  1. Headache (pain in head): 3 people, 10.71%
  2. Oedema Peripheral (superficial swelling): 3 people, 10.71%
  3. Diarrhea: 3 people, 10.71%
  4. Renal Impairment (severely reduced kidney function): 3 people, 10.71%
  5. Blood Creatine Phosphokinase Increased: 3 people, 10.71%
  6. Pain In Extremity: 3 people, 10.71%
  7. Muscle Aches (muscle pain): 2 people, 7.14%
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 2 people, 7.14%
  9. Dyspnea (difficult or laboured breathing): 1 person, 3.57%
  10. Enlarged Heart: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hospitalisation:

All the conditions that are associated with Hospitalisation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hospitalisation and Dyslipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: